The Klinique Medical Clinic PCL (BKK:KLINIQ) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:KLINIQ The Klinique Medical Clinic PCL BKK:KLINIQ
90 GF Score
Price ฿27.50
GF Value ฿44.59
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is The Klinique Medical Clinic PCL Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of The Klinique Medical Clinic PCL is: Low Risk: Strong fundamentals, worth long-term holding.

The Klinique Medical Clinic PCL  (BKK:KLINIQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

The Klinique Medical Clinic PCL Risk Assessment Related Terms

BKK:KLINIQ vs ROL, SCI, HRB: Risk Assessment Comparison

For the Personal Services subindustry, The Klinique Medical Clinic PCL's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Klinique Medical Clinic PCL Risk Assessment vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, The Klinique Medical Clinic PCL's Risk Assessment distribution charts can be found below:

* The bar in red indicates where The Klinique Medical Clinic PCL's Risk Assessment falls into.


BKK:KLINIQ
90GF Score
The Klinique Medical Clinic PCL BKK:KLINIQ
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?

Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued. The current stock price of ฿27.50 is trading 38.3% below its estimated GF Value™ of ฿44.59. GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.

Key valuation signals for BKK:KLINIQ:

  • Risk Assessment:
  • GF Value™: ฿44.59 vs. price of ฿27.50 (38.3% below fair value)
  • GF Score™: 90/100 with 6 warning signs

No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Klinique Medical Clinic PCL Business Description

Address New Petchburi Road, 2922/296-299, Charn Issara Tower 2, 27th Floor, Bangkapi, Huay Kwang, Bangkok, THA, 10310
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
90GF Score

Get the complete analysis for BKK:KLINIQ

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿27.50
Price
฿44.59
GF Value